CHronic Nonbacterial Osteomyelitis International Registry
Launched by SEATTLE CHILDREN'S HOSPITAL · Jan 22, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The CHronic Nonbacterial Osteomyelitis International Registry is a research study that aims to better understand a condition called chronic recurrent multifocal osteomyelitis (CRMO) or chronic nonbacterial osteomyelitis (CNO). This study is looking at how the disease progresses over time and how different treatments affect patients. It will collect data for about 10 years to learn more about the experiences of people with this condition.
To participate in this study, you need to be 21 years old or younger and have certain signs of the disease, such as bone swelling seen on specific MRI scans. Additionally, you will need to have imaging tests done to check for the disease. However, if you have a history of cancer or current bone infections, you won’t be eligible to join. If you do participate, you can expect to provide information about your health and treatments over the years, helping researchers gather valuable insights to improve care for others with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Age at enrollment is equal to or younger than 21 years of age
- • Presence of bone edema on STIR or T2 fat saturation sequence on MRI within 12 weeks of enrollment
- • Whole body imaging evaluation (either WB MRI or bone scintigraphy)
- • Bone biopsy to exclude infection or malignancy unless bone lesions follow typical distribution or there is IBD, psoriasis, or palmar plantar pustulosis
- Exclusion Criteria:
- • - History of or current malignancy
- • Current infectious osteomyelitis
- • Contraindication to the selected treatment agent
About Seattle Children's Hospital
Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials